Clindamycin phosphate 1.2% / Adapalene 0.15% / Benzoyl peroxide 3.1% Therapeutic Cheat Sheet
Cabtreo is the first FDA-approved fixed-dose triple-combination topical treatment for acne vulgaris, pairing a lincosamide antibiotic (clindamycin), a synthetic retinoid (adapalene), and a keratolytic oxidizing agent (benzoyl peroxide) into a single once-daily gel. This formulation targets several pillars of acne pathogenesis simultaneously: cutaneous C. acnes proliferation, abnormal keratinizatio …
Cabtreo is the first FDA-approved fixed-dose triple-combination topical treatment for acne vulgaris, pairing a lincosamide antibiotic (clindamycin), a synthetic retinoid (adapalene), and a keratolytic oxidizing agent (benzoyl peroxide) into a single once-daily gel. This formulation targets several pillars of acne pathogenesis simultaneously: cutaneous C. acnes proliferation, abnormal keratinizatio … 
Prurigo nodularis (PN) is far more than just a persistent itch—it is a distinct, neuroimmune-driven disease entity that demands its own targeted diagnostic and therapeutic roadmap. During a standout session at this year's Skin of Color Update in New York City, Dr. Raj Chovatiya challenged the long-held notion that PN is merely a variant of atopic dermatitis. For patients with skin of color, wher … 
Artificial intelligence (AI) is rapidly changing dermatology, and combining AI with dermoscopy is promising unprecedented diagnostic precision. However, as these technologies advance, a critical question remains: Are they designed to serve all patients equally?
Current diagnostic tools often underperform in patients with skin of color due to biases in training data and a lack of standardized i … 
Throughout your dermatology training, you will pour over thousands of clinical photographs as you learn to identify various conditions. This will be coupled with viewing patients in person and learning to identify subtleties in morphology and presentation to make a diagnosis. No matter how robust and busy your training center is, it would be impossible to see everything. Therefore, the clinical im … 
At the most recent Skin of Color Update conference in New York City, Dr. Cheryl Burgess and Dr. Michelle Henry shared their perspectives on the evolving landscape of cosmetic dermatology, highlighting both established treatments and cutting-edge innovations that are reshaping aesthetic care for patients with skin of color.
Expanding Indications and FDA Approvals
Dr. Burgess, who has witnessed th …